Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study. - Bishnoi, Sarwan; Kotasek, Dusan; Aghmesheh, Morteza; Yau, Thomas; Cosman, Rasha; Prawira, Amy; Moore, Maggie; Chan, Stephen L.; Mant, Andrew; Eek, Richard; Zielinski, Robert; Su, Rila; et al. (Cancer (0008543X), 2024)